<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

COVID-19 Severity in Pediatric Patients With MS on B-Cell-Depleting Therapies: Teri Schreiner, MD

Default sub title

minute read

by Neurology Live | May 18, 2023
placeholder

Throughout the COVID-19 pandemic, the severity of the infection varied significantly among different populations of patients.

Topics: Press Coverage